A wide range of industries are primed to take advantage of the deal to evade EU consumer safeguards and drug pricing rules.
Before the hearing, two major industry groups sent letters outlining their agendas for the Brexit negotiations in 2019.
Silicon Valley, similarly, views Brexit as a chance to bypass EU-wide limits on data collection, or even new U.K.-based rules.
Several technology lobbyists have pushed to provide trade provisions between the U.S. and U.K. that outlaw so-called data localization requirements.
The Institute of Economic Affairs, a major conservative think tank in London, has met repeatedly with Conservative Party leaders and American trade officials to shape a new U.S.-U.K. trade deal that mirrors the demands of industry groups.

Comments to: Lobbyists Seek Brexit Deal That Raises Drug Prices, Shreds Consumer Safeguards

Your email address will not be published. Required fields are marked *

Attach images - Only PNG, JPG, JPEG and GIF are supported.


Welcome to Typer

Brief and amiable onboarding is the first thing a new user sees in the theme.
Join Typer
Registration is closed.